Establishment of an in vitro estrogen-dependent mouse mammary tumor model: A new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions

Breast Cancer Research and Treatment

Volumn 116, Issue 2, 2009, Pages 247-255

  Pontiggia, Osvaldo ^a   Rodriguez, Vanina ^a   Fabris, Victoria ^b   Raffo, Diego ^a   Bumaschny, Viviana ^c   Fiszman, Gabriel ^a   De Kier Joffé, Elisa Bal ^a,d   Simian, Marina ^a,d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c Inst de Ing Genet y Biol Molec   (Argentina)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Breast cancer; Estrogen receptor; In vitro mouse model; Tamoxifen

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN; ESTRADIOL; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; TAMOXIFEN; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOGENETICS; DRUG ACTIVITY; DRUG SENSITIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; IN VITRO STUDY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; ESTRADIOL; ESTROGENS; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU HYBRIDIZATION, FLUORESCENCE; IN SITU NICK-END LABELING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRANSLOCATION, GENETIC;

EID: 67649231486     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0113-3     Document Type: Article

References (17)

1. Bernhardt G, Beckenlehner K, Spruss T, Schlemmer R, Reile H, SchonenbergerH(2002) Establishment and characterization of new murine breast cancer cell lines. Arch Pharm (Weinheim) 335:55-68. doi:10.1002/1521- 4184(200203)335:2/3\55::AID-ARDP55[3.0. CO;2-Y
2. Commitee on Standardized Genetic Nomenclature for Mice Standard karyotype of the mouse (1972) Mus musculus. J Hered 63:69-72
3. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ (1978) Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38:3352-3364
4. Fukino K, Shen L, Patocs A, Mutter GL, Eng C (2007) Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 297:2103-2111. doi:10.1001/jama.297.19.2103
5. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D et al (2008) Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13:394-406. doi:10.1016/j.ccr.2008.03. 007
6. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M et al (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659-670. doi:10.1016/ 0014-2964(79)90139-7
7. Lacey JV Jr, Devesa SS, Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82-88. doi:10.1002/em.10062
8. Lanari C, Kordon E, Molinolo A, Pasqualini CD, Charreau EH (1989) Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. Int J Cancer 43:845-850. doi:10.1002/ ijc.2910430518
9. Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA et al (2001) Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer Res 61:293-302
10. Parkin DM (2004) International variation. Oncogene 23:6329- 6340. doi:10.1038/sj.onc.1207726
11. Russo J, Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102:89-96. doi: 10.1016/j.jsbmb.2006.09.004
12. Shekhar MP, Santner S, Carolin KA, Tait L (2007) Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 170:1546-1560. doi:10.2353/ ajpath.2007.061004
13. Simian M, Manzur T, Rodriguez V, de Kier Joffe EB, Klein S (2008) A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormoneresponsiveness in immune competent mice. Breast Cancer Res Treat (in press)
14. Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416
15. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119-150. doi: 10.1146/annurev.pathol.1.110304. 100224
16. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, Ostrowski MC, Leone G (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68:937-945. doi:10.1158/ 0008-5472.CAN-07-2148
17. Watson CS, Medina D, Clark JH (1977) Estrogen receptor characterization in a transplantable mouse mammary tumor. Cancer Res 37:33-44